Xiaomin Kang
- Molecular Biology
- Nephrology top 10%
- Complementary and alternative medicine top 10%
- Pharmacology
- Cancer Research
- Topics
- Diabetes Treatment and Management (4 papers)COVID-19 Clinical Research Studies (3 papers)Chronic Kidney Disease and Diabetes (3 papers)
- Partner nations
- China
In The Last Decade
Xiaomin Kang
17 papers receiving 281 citations
Peers
Comparison fields: 5 of 71
- Molecular Biology 114
- Nephrology 70
- Complementary and alternative medicine 38
- Pharmacology 31
- Cancer Research 29
Countries citing papers authored by Xiaomin Kang
This map shows the geographic impact of Xiaomin Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomin Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomin Kang more than expected).
Fields of papers citing papers by Xiaomin Kang
This network shows the impact of papers produced by Xiaomin Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomin Kang. The network helps show where Xiaomin Kang may publish in the future.
Co-authorship network of co-authors of Xiaomin Kang
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaomin Kang. A scholar is included among the top collaborators of Xiaomin Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaomin Kang. Xiaomin Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 5 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 9 | |
| 7 | 13 | |
| 8 | 11 | |
| 9 | 6 | |
| 10 | 4 | |
| 11 | 6 | |
| 12 | 3 | |
| 13 | 42 | |
| 14 | 5 | |
| 15 | 21 | |
| 16 | 147 | |
| 17 | 5 |
About Xiaomin Kang
Xiaomin Kang is a scholar working on Nephrology, Pharmacology and Complementary and alternative medicine, having authored 17 papers that have together received 284 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (4 papers), COVID-19 Clinical Research Studies (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). The work is most often cited by research in Nephrology (70 citations), Complementary and alternative medicine (38 citations) and Clinical Biochemistry (26 citations). Xiaomin Kang has collaborated with scholars based in China. Frequent co-authors include De Jin, Yuting Sun, Fengmei Lian, Yuqing Zhang, Rongrong Zhou, Liyun Duan, Yuehong Zhang, Xuedong An, Yingying Duan and Cunqing Yang. Their work appears in journals such as Gene, Frontiers in Pharmacology and Diabetes Obesity and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.